发明名称 |
Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid |
摘要 |
This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I), to pharmaceutical compositions comprising this salt, to processes for forming this salt and to its use in medical treatment. In addition, the present invention also relates to new polymorphic forms of the hemifumarate salt form of Compound I, as well as to pharmaceutical compositions comprising these polymorphic forms, to processes for obtaining them, and their use in medical treatment. |
申请公布号 |
AU2009335924(A1) |
申请公布日期 |
2011.06.30 |
申请号 |
AU20090335924 |
申请日期 |
2009.12.16 |
申请人 |
NOVARTIS AG |
发明人 |
CISZEWSKI, LECH;DE LA CRUZ, MARILYN;KARPINSKI, PIOTR H.;MUTZ, MICHAEL;RIEGERT, CHRISTIAN;VOGEL, CASPAR;SCHNEEBERGER, RICARDO |
分类号 |
C07D205/04;A61K31/397;A61P35/00;A61P37/00 |
主分类号 |
C07D205/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|